Homocysteine metabolism and B-vitamins in schizophrenic patients: low plasma folate as a possible independent risk factor for schizophrenia
- 1 November 2003
- journal article
- Published by Elsevier in Psychiatry Research
- Vol. 121 (1) , 1-9
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Association between B vitamin intake and plasma homocysteine concentration in the general Dutch population aged 20–65 yThe American Journal of Clinical Nutrition, 2001
- Is Mutated Serine Hydroxymethyltransferase (SHMT) Involved in the Etiology of Neural Tube Defects?Molecular Genetics and Metabolism, 2001
- Association between the methylenetetrahydrofolate reductase 677C→T missense mutation and schizophreniaMolecular Psychiatry, 2000
- Folate levels in psychiatric outpatientsPsychiatry and Clinical Neurosciences, 1999
- Folate and cobalamin in psychiatric illnessComprehensive Psychiatry, 1997
- Methylenetetrahydrofolate reductase variant and schizophrenia/depressionAmerican Journal of Medical Genetics, 1997
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin SupplementationNew England Journal of Medicine, 1992
- Platelet Methylene Reductase Activity in SchizophreniaArchives of General Psychiatry, 1977
- Folate-Responsive Homocystinuria and “Schizophrenia”New England Journal of Medicine, 1975